Benoxaprofen-13C, d3

Benoxaprofen-13C, d3 (LRCL 3794-13C, d3) is the deuterium and 13C-labeled Benoxaprofen. Benoxaprofen (LRCL 3794) is a potent and long-acting anti-inflammatory and antipyretic compound. Benoxaprofen is a relatively weak inhibitor of cyclooxygenase in in vitro systems, inhibits lipoxygenase in other systems, and inhibits monocyte migration in some animal models of inflammation[1][2].

1329840-53-0

LRCL 3794-13C, d3

12352005

COX; Isotope-Labeled Compounds

Immunology/Inflammation; Others

COVID-19-immunoregulation

Inflammation/Immunology

[2H][13C]([2H])(C(C(O)=O)C1=CC2=C(OC(C3=CC=C(Cl)C=C3)=N2)C=C1)[2H]

C15 13CH9D3ClNO3

305.74

[1]Cashin CH, et al. The pharmacology of benoxaprofen (2-[4-chlorophenyl]-alpha-methyl-5-benzoxazole acetic acid), LRCL 3794, a new compound with antiinflammatory activity apparently unrelated to inhibition of prostaglandin synthesis. J Pharm Pharmacol. 1977;29 (6) :330-336.

Room temperature

http://file.medchemexpress.com/batch_PDF/HY-W778179/

Isotope-Labeled Compounds

No Development Reported